217 related articles for article (PubMed ID: 28560411)
1. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
Wang Q
Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
[TBL] [Abstract][Full Text] [Related]
2. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
Chen XG; Ma L; Xu JX
Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
[TBL] [Abstract][Full Text] [Related]
3. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
[TBL] [Abstract][Full Text] [Related]
4. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
6. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
7. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis.
Dong B; Wang G; Yao J; Yuan P; Kang W; Zhi L; He X
Gene; 2017 Sep; 628():32-37. PubMed ID: 28687333
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of gene expression, miRNA expression and DNA methylation profiles of osteosarcoma.
Zhang W; Han S; Sun K
Oncol Rep; 2017 Feb; 37(2):1175-1181. PubMed ID: 28000890
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of the effects and mechanisms of decitabine and cytarabine on acute myeloid leukemia.
Zhou S; Liu P; Zhang H
Mol Med Rep; 2017 Jul; 16(1):281-287. PubMed ID: 28498449
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
[TBL] [Abstract][Full Text] [Related]
12. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential crucial genes and key pathways in osteosarcoma.
Liu J; Wu S; Xie X; Wang Z; Lei Q
Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
Xiong Y; Wu S; Du Q; Wang A; Wang Z
Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
[TBL] [Abstract][Full Text] [Related]
15. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
Li M; Jin X; Guo F; Wu G; Wu L; Deng S
J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
[TBL] [Abstract][Full Text] [Related]
19. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
20. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.
Liu Y; Guan J; Chen X
Pathol Oncol Res; 2019 Jul; 25(3):1091-1102. PubMed ID: 30411296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
